Ignite Creation Date:
2024-05-05 @ 11:44 PM
Last Modification Date:
2024-10-26 @ 10:38 AM
Study NCT ID:
NCT01406470
Status:
COMPLETED
Last Update Posted:
2014-01-10
First Post:
2011-07-26
Brief Title:
Phase 3 Study of Immune Globulin Intravenous HumanIVIG-SN in Subjects With Primary Immunodeficiency
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp